Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Accelerated Pharma Inc. (NASDAQ: ACCP)

$0.00 USD $0.00 (0.00%)
Last Price $
Net Change $ (%)
Bid $
Ask Price $
Open Price $
Previous Close Price $
High Price $
Low Price $
Number of Trades
Volume
Fifty Two Week High $ (1969-12-31)
Fifty Two Week Low $ (1969-12-31)
Average Daily Volume
Share Outstanding Shares
Total Dividend Payout /yr
Dividend Yield %
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $
EPS Growth $0
Recent Earnings $
Annual EPS $
Last Quarter EPS $
Market Capitalization $0.00B
Insider Shareholders % 0.09%
Annual Revenue $0B
No. Shares Outstanding
Inst. Shareholder % 0.46%
Annual Net Income $-0.01B
TTM Net Profit Margin $0
1-Year Return %
3-Year Return %
5-Year Return %
5-Year Revenue Growth %
5-Year Earnings Growth %
5-Year Dividend Growth %
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 0%
Dividends per Share $
Stock Split Ratio
Beta
Access Pharmaceuticals Inc is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase II clinical testing of patients with ovarian cancer and MuGard(TM) for the treatment of patients with mucositis. The Company also has other advanced drug delivery technologies including vitamin-mediated targeted delivery and oral drug delivery. The company has proprietary patents to four drug delivery technology platforms: synthetic polymer targeted delivery, vitamin mediated targeted delivery, vitamin mediated oral delivery, and mucoadhesive liquid technology. The Company has headquartered in Dallas, Texas.

ACCP News & Stock Updates